Who Attends?

The therapeutic potential of the human microbiome shows great promise, but in order for this potential to be realized, lessons and key insights from organizations who are directly involved in developing microbiome-based therapeutics & biomarkers must be shared and disseminated. The Microbiome Movement – Drug Development Summit’s exclusive focus on overcoming the challenges of therapeutic & biomarker development means it’s an unparalleled opportunity for you to engage in meaningful discussion with 250+ pharmaceutical, biotech and translational researchers at the forefront of this growing field.

Snapshot of Previous Attendees




Pharma companies
Biotechs companies
Academics companies

Audience Breakdown

Microbiome Movement - audience breakdown

"Microbiome Movement — Drug Development Summit continues to be an important conference for individuals looking to understand developments in therapeutics and diagnostics in this novel drug modality"

Matthew Henn, Seres Therapeutics